CMFRI's natural product from seaweeds to combat fatty liver disease to hit market soon

CMFRI, Library (2022) CMFRI's natural product from seaweeds to combat fatty liver disease to hit market soon. Aquaculture Spectrum, 5 (12). p. 66. ISSN 2581-7892

[img]
Preview
Text
Aquaculture Spectrum_2022_Natural Product.pdf

Download (65kB) | Preview
Official URL: https://www.aquaoutlook.com/
Related URLs:

    Abstract

    CadalminTM LivCure extract, a patent-protected nutraceutical product developed by the ICARCentral Marine Fisheries Research Institute (CMFRI) from seaweeds to combat non-alcoholic fatty liver disease (NAFLD) will hit the markets soon. CMFRI signed a Memorandum of Understanding (MoU) with M/s. Emineotech, a private limited company dealing with health products, for commercial production and marketing. Dr. A. Gopalakrishnan, Director of CMFRI signed a license agreement with Mr. Evanjalist Pathrose, Managing Director of Emineotech.

    Item Type: Article
    Uncontrolled Keywords: Seaweed; fatty liver disease
    Subjects: Biochemistry
    Algae > Seaweed
    Divisions: Library and Documentation Centre
    Depositing User: Arun Surendran
    Date Deposited: 27 Sep 2010 07:37
    Last Modified: 10 Mar 2023 11:20
    URI: http://eprints.cmfri.org.in/id/eprint/4462

    Actions (login required)

    View Item View Item